CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
6.31
+0.43 (7.41%)
At close: Jul 8, 2025, 4:00 PM
6.06
-0.25 (-3.89%)
After-hours: Jul 8, 2025, 6:46 PM EDT
CervoMed Market Cap
CervoMed has a market cap or net worth of $54.87 million as of July 8, 2025. Its market cap has decreased by -65.79% in one year.
Market Cap
54.87M
Enterprise Value
19.63M
1-Year Change
-65.79%
Ranking
Category
Stock Price
$6.31
Market Cap Chart
Since June 30, 2008, CervoMed's market cap has increased from $1.50M to $54.87M, an increase of 3,558.04%. That is a compound annual growth rate of 23.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 7, 2025 | 51.10M | 164.77% |
Dec 31, 2024 | 19.30M | -55.43% |
Dec 29, 2023 | 43.30M | 320.39% |
Dec 30, 2022 | 10.30M | -66.88% |
Dec 31, 2021 | 31.10M | -38.90% |
Dec 31, 2020 | 50.90M | 2,213.64% |
Dec 31, 2019 | 2.20M | -67.16% |
Dec 31, 2018 | 6.70M | -60.82% |
Dec 29, 2017 | 17.10M | -26.92% |
Dec 30, 2016 | 23.40M | 25.81% |
Dec 31, 2015 | 18.60M | -69.71% |
Dec 31, 2014 | 61.40M | 361.65% |
Dec 31, 2013 | 13.30M | -22.22% |
Dec 31, 2012 | 17.10M | -60.87% |
Dec 30, 2011 | 43.70M | 54.42% |
Dec 31, 2010 | 28.30M | -75.81% |
Dec 31, 2009 | 117.00M | 39.62% |
Dec 31, 2008 | 83.80M | 5,486.67% |
View and export this data all the way back to 2008.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 698.13B |
Johnson & Johnson | 374.84B |
AbbVie | 335.21B |
Novo Nordisk | 313.36B |
UnitedHealth Group | 279.13B |
Novartis AG | 240.15B |
Abbott Laboratories | 232.02B |
AstraZeneca | 217.48B |